Newborn Screening Data Monitoring and Reporting for Haemoglobinopathies

This opportunity involves providing screening outcome monitoring services and comprehensive data collection to support mandatory Key Performance Indicator (KPI) reporting for haemoglobinopathy detection in newborn screening programs. The successful provider will establish systems to track screening results, manage data quality, and deliver regular reports demonstrating compliance with national screening standards and performance targets for conditions such as sickle cell disease and thalassemia.